Imfinzi, Lynparza Combination Improves PFS in Patients With

Imfinzi, Lynparza Combination Improves PFS in Patients With Ovarian Cancer in Phase 3 Trial

Individuals treated with the drugs from AstraZeneca demonstrate clinically meaningful and statistically significant improvement.

Related Keywords

Germany , Susan Galbraith , Kliniken Essen Mitte , Philipp Harter , Astrazeneca ,

© 2025 Vimarsana